- Filed
- May 20, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 20, 2026 | 815.92K sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 20.17K sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 29 sh |
| Capex | Q1 2026 · Mar 31, 2026 | $10.38K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$4.58M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$11.71M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | −$33.28M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $5.61M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $13.34M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $12.22M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $49.08M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $12.56M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $850.01K |
| Current Assets | Q1 2026 · Dec 31, 2025 | $3.82M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $13.91M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $16.52M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$790.49 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$198,072.98 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$790.49 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | −$198,072.98 |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $1.05M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $1.21M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$15.95M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$5.71M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$4.36M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$5.61M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $2.87K |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $284 |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $9.29K |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $734 |
| Revenue | Q1 2026 · Mar 31, 2026 | $12.16K |
| Revenue | Q1 2026 · Mar 31, 2025 | $1.02K |